Short answer
Cullinan Therapeutics, Inc. (CGEM) filed an 8-K current report with the SEC on June 16, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders re-elected Nadim Ahmed and Stephen Webster as Class III directors for three-year terms.
Cullinan Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders re-elected Nadim Ahmed and Stephen Webster as Class III directors for three-year terms
- KPMG LLP appointment ratified for fiscal year ending December 31, 2026, with 53,722,477 votes for
- Executive compensation approved on an advisory basis, with 48,536,734 votes for
- Director elections included 4,126,430 broker non-votes, signaling some shares lacked voting instructions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cullinan Therapeutics, Inc. 8-K filings
Get the next CGEM 8-K as it lands
Follow CGEM for push alerts, or ask the research agent what this filing means.